{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:39:39Z","timestamp":1794591579974,"version":"4.9.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12011-019-01931-z","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T09:05:13Z","timestamp":1572944713000},"page":"375-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["The Role of Magnesium in Pathophysiology and Migraine Treatment"],"prefix":"10.1007","volume":"196","author":[{"given":"Sanam","family":"Dolati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Rikhtegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Mehdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"issue":"1","key":"1931_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"M Arnold","year":"2018","unstructured":"Arnold M (2018) Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"issue":"10053","key":"1931_CR2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"T Vos","year":"2016","unstructured":"Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1545\u20131602","journal-title":"Lancet"},{"issue":"7","key":"1931_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41(7):646\u2013657","journal-title":"Headache"},{"issue":"4","key":"1931_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10194-010-0217-0","volume":"11","author":"LJ Stovner","year":"2010","unstructured":"Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289","journal-title":"J Headache Pain"},{"issue":"2","key":"1931_CR5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622","journal-title":"Physiol Rev"},{"key":"1931_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.biopha.2018.05.050","volume":"104","author":"S Dolati","year":"2018","unstructured":"Dolati S, Marofi F, Babaloo Z, Aghebati-Maleki L, Roshangar L, Ahmadi M, Rikhtegar R, Yousefi M (2018) Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis. Biomed Pharmacother 104:280\u2013290","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1931_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/WCO.0000000000000687","volume":"32","author":"I de Boer","year":"2019","unstructured":"de Boer I, van den Maagdenberg AM, Terwindt GM (2019) Advance in genetics of migraine. Curr Opin Neurol 32(3):413\u2013421","journal-title":"Curr Opin Neurol"},{"issue":"1-2","key":"1931_CR8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cca.2009.08.007","volume":"409","author":"AY Shuen","year":"2009","unstructured":"Shuen AY, Wong BY, Wei C, Liu Z, Li M, Cole DE (2009) Genetic determinants of extracellular magnesium concentration: analysis of multiple candidate genes, and evidence for association with the estrogen receptor \u03b1 (ESR1) locus. Clin Chim Acta 409(1-2):28\u201332","journal-title":"Clin Chim Acta"},{"issue":"9","key":"1931_CR9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Society HCCotIH","year":"2013","unstructured":"Society HCCotIH (2013) The international classification of headache disorders, (beta version). Cephalalgia 33(9):629\u2013808","journal-title":"Cephalalgia"},{"key":"1931_CR10","unstructured":"Ong JJY, De Felice M (2017) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics:1\u201317"},{"key":"1931_CR11","unstructured":"Khairmode DV, Kapare PR, Jadhav KL, Khade RH, Keskar CH, Ghongade KD, Kamble R, Mali AS (2018) Migraine is not just a headache. Pharma Sci Monit 9(1)"},{"issue":"10","key":"1931_CR12","first-page":"958","volume":"25","author":"N Giffin","year":"2005","unstructured":"Giffin N, Lipton R, Silberstein S, Tvedskov J, Olesen J, Goadsby P (2005) The migraine postdrome: an electronic diary study. Cephalalgia 25(10):958","journal-title":"Cephalalgia"},{"issue":"14","key":"1931_CR13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0333102414532554","volume":"34","author":"M Louter","year":"2014","unstructured":"Louter M, Wardenaar K, Veen G, van Oosterhout W, Zitman F, Ferrari M, Terwindt G (2014) Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia 34(14):1187\u20131192","journal-title":"Cephalalgia"},{"key":"1931_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fneur.2018.00019","volume":"9","author":"O Cozzolino","year":"2018","unstructured":"Cozzolino O, Marchese M, Trovato F, Pracucci E, Ratto GM, Buzzi MG, Sicca F, Santorelli FM (2018) Understanding spreading depression from headache to sudden unexpected death. Front Neurol 9:19","journal-title":"Front Neurol"},{"issue":"5","key":"1931_CR15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00702-012-0790-2","volume":"119","author":"A Mauskop","year":"2012","unstructured":"Mauskop A, Varughese J (2012) Why all migraine patients should be treated with magnesium. J Neural Transm 119(5):575\u2013579","journal-title":"J Neural Transm"},{"issue":"1","key":"1931_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10534-013-9684-5","volume":"27","author":"R Agarwal","year":"2014","unstructured":"Agarwal R, Agarwal P (2014) Pathogenetic role of magnesium deficiency in ophthalmic diseases. Biometals 27(1):5\u201318","journal-title":"Biometals"},{"issue":"4","key":"1931_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-2982.2005.01059.x","volume":"26","author":"M Sparaco","year":"2006","unstructured":"Sparaco M, Feleppa M, Lipton R, Rapoport A, Bigal M (2006) Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26(4):361\u2013372","journal-title":"Cephalalgia"},{"issue":"17","key":"1931_CR18","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","volume":"35","author":"R Burstein","year":"2015","unstructured":"Burstein R, Noseda R, Borsook D (2015) Migraine: multiple processes, complex pathophysiology. J Neurosci 35(17):6619\u20136629","journal-title":"J Neurosci"},{"issue":"1","key":"1931_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.23861\/EJBM20112718","volume":"27","author":"TN Liebman","year":"2016","unstructured":"Liebman TN, Crystal SC (2016) What is the evidence that riboflavin can be used for migraine prophylaxis? Einstein J Biol Med 27(1):7\u20139","journal-title":"Einstein J Biol Med"},{"key":"1931_CR20","doi-asserted-by":"crossref","unstructured":"Cevoli S, Favoni V, Cortelli P (2019) Energy metabolism impairment in migraine. Curr Med Chem","DOI":"10.2174\/0929867325666180622154411"},{"issue":"1","key":"1931_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12691\/ajbr-6-1-3","volume":"6","author":"S Chhater","year":"2018","unstructured":"Chhater S, Karal R, Kumar B (2018) Review on migraine: pathophysiology and treatment. Am J Biomed Res 6(1):20\u201324","journal-title":"Am J Biomed Res"},{"issue":"2","key":"1931_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0972-2327.182302","volume":"19","author":"R Malhotra","year":"2016","unstructured":"Malhotra R (2016) Understanding migraine: potential role of neurogenic inflammation. Ann Indian Acad Neurol 19(2):175\u2013182","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"1931_CR23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","volume":"6","author":"TW Ho","year":"2010","unstructured":"Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6(10):573\u2013582","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1931_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","volume":"15","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Charles A (2018) Glutamate and its receptors as therapeutic targets for migraine. Neurotherapeutics 15(2):361\u2013370","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1931_CR25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5214\/ans.0972.7531.12190210","volume":"19","author":"M Aggarwal","year":"2012","unstructured":"Aggarwal M, Puri V, Puri S (2012) Serotonin and CGRP in migraine. Ann Neurosci 19(2):88\u201394","journal-title":"Ann Neurosci"},{"issue":"1-2","key":"1931_CR26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2298\/MPNS1302053K","volume":"66","author":"Z Koji\u0107","year":"2013","unstructured":"Koji\u0107 Z, Stojanovi\u0107 D (2013) Pathophysiology of migraine: from molecular to personalized medicine. Med Pregl 66(1-2):53\u201357","journal-title":"Med Pregl"},{"issue":"10","key":"1931_CR27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1586\/ern.11.110","volume":"11","author":"J Hoffmann","year":"2011","unstructured":"Hoffmann J (2011) Recent advances in headache research. Expert Rev Neurother 11(10):1379\u20131381","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"1931_CR28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11916-011-0231-1","volume":"16","author":"G Coppola","year":"2012","unstructured":"Coppola G, Schoenen J (2012) Cortical excitability in chronic migraine. Curr Pain Headache Rep 16(1):93\u2013100","journal-title":"Curr Pain Headache Rep"},{"key":"1931_CR29","doi-asserted-by":"crossref","unstructured":"Karsan N, Goadsby PJ (2018) Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol:1","DOI":"10.1038\/s41582-018-0098-4"},{"issue":"10","key":"1931_CR30","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.pain.2011.07.002","volume":"152","author":"AR Charbit","year":"2011","unstructured":"Charbit AR, Akerman S, Goadsby PJ (2011) Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. PAIN\u00ae 152(10):2365\u20132376","journal-title":"PAIN\u00ae"},{"issue":"1","key":"1931_CR31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s10194-017-0722-5","volume":"18","author":"Z Chen","year":"2017","unstructured":"Chen Z, Chen X, Liu M, Dong Z, Ma L, Yu S (2017) Altered functional connectivity of amygdala underlying the neuromechanism of migraine pathogenesis. J Headache Pain 18(1):7","journal-title":"J Headache Pain"},{"issue":"2","key":"1931_CR32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","volume":"15","author":"JJY Ong","year":"2018","unstructured":"Ong JJY, De Felice M (2018) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics 15(2):274\u2013290","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1931_CR33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1526-4610.2011.01847.x","volume":"51","author":"FR Taylor","year":"2011","unstructured":"Taylor FR (2011) Nutraceuticals and headache: the biological basis. Headache 51(3):484\u2013501","journal-title":"Headache"},{"issue":"1","key":"1931_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00012.2014","volume":"95","author":"JH De Baaij","year":"2015","unstructured":"De Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95(1):1\u201346","journal-title":"Physiol Rev"},{"key":"1931_CR35","first-page":"49","volume-title":"Magnesium in health and disease","author":"AM Romani","year":"2013","unstructured":"Romani AM (2013) Magnesium in health and disease. Interrelations between essential metal ions and human diseases. Springer, In, pp 49\u201379"},{"issue":"10","key":"1931_CR36","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/0333102414564891","volume":"35","author":"L Teigen","year":"2015","unstructured":"Teigen L, Boes CJ (2015) An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia 35(10):912\u2013922","journal-title":"Cephalalgia"},{"issue":"3","key":"1931_CR37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1586\/14737175.9.3.369","volume":"9","author":"C Sun-Edelstein","year":"2009","unstructured":"Sun-Edelstein C, Mauskop A (2009) Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 9(3):369\u2013379","journal-title":"Expert Rev Neurother"},{"key":"1931_CR38","doi-asserted-by":"crossref","unstructured":"Pizza V, Milano W, Padricelli U, Capasso A (2017) NOVEL THERAPEUTIC INVESTIGATIONS IN MIGRAINE PAIN","DOI":"10.15761\/CMI.1000148"},{"key":"1931_CR39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2018.03.059","volume":"102","author":"E Nattagh-Eshtivani","year":"2018","unstructured":"Nattagh-Eshtivani E, Sani MA, Dahri M, Ghalichi F, Ghavami A, Arjang P, Tarighat-Esfanjani A (2018) The role of nutrients in the pathogenesis and treatment of migraine headaches. Biomed Pharmacother 102:317\u2013325","journal-title":"Biomed Pharmacother"},{"key":"1931_CR40","doi-asserted-by":"crossref","unstructured":"Kirkland AE, Sarlo GL, Holton KF (2018) The Role of Magnesium in Neurological Disorders. Nutrients 10(6)","DOI":"10.3390\/nu10060730"},{"key":"1931_CR41","doi-asserted-by":"crossref","unstructured":"Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D\u2019Amato CC (2004) Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis.","DOI":"10.1016\/S0083-6729(04)69011-X"},{"key":"1931_CR42","doi-asserted-by":"crossref","unstructured":"Hoffmann J, Charles A (2018) Glutamate and its receptors as therapeutic targets for migraine. Neurotherapeutics:1\u201310","DOI":"10.1007\/s13311-018-0616-5"},{"issue":"14","key":"1931_CR43","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/jnr.22467","volume":"88","author":"Y Shindo","year":"2010","unstructured":"Shindo Y, Fujimoto A, Hotta K, Suzuki K, Oka K (2010) Glutamate-induced calcium increase mediates magnesium release from mitochondria in rat hippocampal neurons. J Neurosci Res 88(14):3125\u20133132","journal-title":"J Neurosci Res"},{"key":"1931_CR44","doi-asserted-by":"crossref","unstructured":"Rybicka M, Baranowska-Bosiacka I, Zyluk B, Nowacki P, Chlubek D (2012) The role of magnesium in migraine pathogenesis. Potential use of magnesium compounds in prevention and treatment of migraine headaches. J Elementol 17(2)","DOI":"10.5601\/jelem.2012.17.2.15"},{"issue":"11-12","key":"1931_CR45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00438-012-0723-7","volume":"287","author":"S Stuart","year":"2012","unstructured":"Stuart S, Griffiths LR (2012) A possible role for mitochondrial dysfunction in migraine. Mol Gen Genomics 287(11-12):837\u2013844","journal-title":"Mol Gen Genomics"},{"issue":"4","key":"1931_CR46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11940-016-0398-1","volume":"18","author":"O Daniel","year":"2016","unstructured":"Daniel O, Mauskop A (2016) Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol 18(4):14","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"1931_CR47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11055-008-9008-3","volume":"38","author":"K Izzati-Zade","year":"2008","unstructured":"Izzati-Zade K (2008) The role of serotonin in the pathogenesis and clinical presentations of migraine attacks. Neurosci Behav Physiol 38(5):501\u2013505","journal-title":"Neurosci Behav Physiol"},{"issue":"2","key":"1931_CR48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/SPC.0000000000000044","volume":"8","author":"G Dussor","year":"2014","unstructured":"Dussor G (2014) Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered. Curr Opin Support Palliat Care 8(2):137","journal-title":"Curr Opin Support Palliat Care"},{"issue":"17","key":"1931_CR49","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","volume":"78","author":"S Holland","year":"2012","unstructured":"Holland S, Silberstein S, Freitag F, Dodick D, Argoff C, Ashman E (2012) Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults:[RETIRED]: report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78(17):1346\u20131353","journal-title":"Neurology"},{"key":"1931_CR50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2018.05.018","volume":"61","author":"S Dolati","year":"2018","unstructured":"Dolati S, Ahmadi M, Rikhtegar R, Babaloo Z, Ayromlou H, Aghebati-Maleki L, Nouri M, Yousefi M (2018) Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis. Int Immunopharmacol 61:74\u201381","journal-title":"Int Immunopharmacol"},{"issue":"5950","key":"1931_CR51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/307462a0","volume":"307","author":"L Nowak","year":"1984","unstructured":"Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307(5950):462","journal-title":"Nature"},{"issue":"3","key":"1931_CR52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1533-2500.2009.00349.x","volume":"10","author":"Y Se\u00e7il","year":"2010","unstructured":"Se\u00e7il Y, \u00dcnde C, Beckmann YY, Bozkaya YT, \u00d6zerkan F, Ba\u015fo\u011flu M (2010) Blood pressure changes in migraine patients before, during and after migraine attacks. Pain Pract 10(3):222\u2013227","journal-title":"Pain Pract"},{"issue":"2","key":"1931_CR53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2008.08.003","volume":"120","author":"J Olesen","year":"2008","unstructured":"Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120(2):157\u2013171","journal-title":"Pharmacol Ther"},{"key":"1931_CR54","first-page":"188","volume":"3","author":"WR Yorns Jr","year":"2013","unstructured":"Yorns WR Jr, Hardison HH (2013) Mitochondrial dysfunction in migraine. Semin Pediatr Neurol 3. Elsevier:188\u2013193","journal-title":"Semin Pediatr Neurol"},{"issue":"4","key":"1931_CR55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40265-018-0865-y","volume":"78","author":"JJY Ong","year":"2018","unstructured":"Ong JJY, Wei DY-T, Goadsby PJ (2018) Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs. Drugs 78(4):411\u2013437","journal-title":"Drugs"},{"issue":"2","key":"1931_CR56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/head.13217","volume":"58","author":"A Von Luckner","year":"2018","unstructured":"Von Luckner A, Riederer F (2018) Magnesium in migraine prophylaxis\u2014is there an evidence-based rationale? A systematic review. Headache 58(2):199\u2013209","journal-title":"Headache"},{"issue":"8","key":"1931_CR57","first-page":"480","volume":"33","author":"G DeMaagd","year":"2008","unstructured":"DeMaagd G (2008) The pharmacological management of migraine, part 2: preventative therapy. Pharm Ther 33(8):480","journal-title":"Pharm Ther"},{"issue":"3","key":"1931_CR58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1526-4610.2006.00631.x","volume":"47","author":"S Diamond","year":"2007","unstructured":"Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB (2007) Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study: CME. Headache 47(3):355\u2013363","journal-title":"Headache"},{"issue":"8","key":"1931_CR59","first-page":"584","volume":"87","author":"C Armstrong","year":"2013","unstructured":"Armstrong C (2013) AAN\/AHS update recommendations for migraine prevention in adults. Am Fam Physician 87(8):584\u2013585","journal-title":"Am Fam Physician"},{"key":"1931_CR60","unstructured":"Chru\u015bcikowska AJJOPH, NURSING, RESCUE M (2015) Migraine prophylaxis in pregnancy\u2013the effects of magnesium. 142 (2015_2):07-10"},{"issue":"4","key":"1931_CR61","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0361-9230(01)00440-3","volume":"54","author":"R Lodi","year":"2001","unstructured":"Lodi R, Iotti S, Cortelli P, Pierangeli G, Cevoli S, Clementi V, Soriani S, Montagna P, Barbiroli B (2001) Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Res Bull 54(4):437\u2013441","journal-title":"Brain Res Bull"},{"issue":"7","key":"1931_CR62","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1503\/cmaj.081657","volume":"182","author":"T Pringsheim","year":"2010","unstructured":"Pringsheim T, Davenport WJ, Becker WJ (2010) Prophylaxis of migraine headache. Can Med Assoc J 182(7):E269\u2013E276","journal-title":"Can Med Assoc J"},{"issue":"6","key":"1931_CR63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1526-4610.2003.03102.x","volume":"43","author":"F Wang","year":"2003","unstructured":"Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43(6):601\u2013610","journal-title":"Headache"},{"issue":"1","key":"1931_CR64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1526-4610.2011.02062.x","volume":"52","author":"NE Kelley","year":"2012","unstructured":"Kelley NE, Tepper DE (2012) Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium. Headache 52(1):114\u2013128","journal-title":"Headache"},{"issue":"5","key":"1931_CR65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1526-4610.1991.hed3105298.x","volume":"31","author":"F Facchinetti","year":"1991","unstructured":"Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31(5):298\u2013301","journal-title":"Headache"},{"issue":"4","key":"1931_CR66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-2982.1996.1604257.x","volume":"16","author":"A Peikert","year":"1996","unstructured":"Peikert A, Wilimzig C, K\u00f6hne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16(4):257\u2013263","journal-title":"Cephalalgia"},{"issue":"1-3","key":"1931_CR67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12011-012-9487-5","volume":"150","author":"AT Esfanjani","year":"2012","unstructured":"Esfanjani AT, Mahdavi R, Mameghani ME, Talebi M, Nikniaz Z, Safaiyan A (2012) The effects of magnesium, l-carnitine, and concurrent magnesium\u2013l-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res 150(1-3):42\u201348","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1931_CR68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s10194-015-0516-6","volume":"16","author":"C Gaul","year":"2015","unstructured":"Gaul C, Diener H-C, Danesch U, Group MS (2015) Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain 16(1):32","journal-title":"J Headache Pain"},{"issue":"1","key":"1931_CR69","first-page":"0-0","volume":"4","author":"V Giorgio Dalla","year":"2017","unstructured":"Giorgio Dalla V, Zavarize P, Ngonga G, Pezzini A, Dalla Volta G (2017) Combination of tanacethum partenium, 5-hydrossitriptophan (5-Http) and magnesium in the prophylaxis of episodic migraine without aura (AURASTOP\u00c2\u00ae) an observational study. Int J Neurol Brain Disord 4(1):0-0","journal-title":"Int J Neurol Brain Disord"},{"issue":"1","key":"1931_CR70","first-page":"11","volume":"5","author":"V Giorgio Dalla","year":"2018","unstructured":"Giorgio Dalla V, Antonaci F, Rebecchi V, Sances G, Merlo P, Giorgetti A, Di Palma F, Matta E, Dallocchio C, Tassorelli C (2018) AURASTOP \u00c2\u00ae in the treatment of migraine aura. Int J Neurol Brain Disord 5(1):11\u201314","journal-title":"Int J Neurol Brain Disord"},{"issue":"08","key":"1931_CR71","first-page":"1","volume":"5","author":"F Mainardi","year":"2018","unstructured":"Mainardi F, Merlo P, Maggioni F, Zanchin G, Dalla Volta G (2018) Efficacy of a combination of tanacetum parthenium, 5-hydroxy tryptophan and magnesium (Aurastop) in episodic migraine prevention: a multicentric observational study. Open Access Library J 5(08):1","journal-title":"Open Access Library J"},{"issue":"1","key":"1931_CR72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12906-017-1933-7","volume":"17","author":"A Guilbot","year":"2017","unstructured":"Guilbot A, Bangratz M, Abdellah SA, Lucas C (2017) A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study. BMC Complement Altern Med 17(1):433","journal-title":"BMC Complement Altern Med"},{"key":"1931_CR73","doi-asserted-by":"crossref","unstructured":"Karimi N, Razian A, Heidari M (2019) The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study. Acta Neurol Belg:1\u20137","DOI":"10.1007\/s13760-019-01101-x"},{"issue":"3","key":"1931_CR74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1526-4610.1996.3603154.x","volume":"36","author":"A Mauskop","year":"1996","unstructured":"Mauskop A, Altura BT, Cracco RQ, Altura BM (1996) Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 36(3):154\u2013160","journal-title":"Headache"},{"issue":"2","key":"1931_CR75","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1526-4610.2001.111006171.x","volume":"41","author":"\u015e Demirkaya","year":"2001","unstructured":"Demirkaya \u015e, Vural O, Dora B, Top\u00e7uo\u011flu MA (2001) Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 41(2):171\u2013177","journal-title":"Headache"},{"issue":"6","key":"1931_CR76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1067\/mem.2001.119424","volume":"38","author":"J Corbo","year":"2001","unstructured":"Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ (2001) Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 38(6):621\u2013627","journal-title":"Ann Emerg Med"},{"issue":"5","key":"1931_CR77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1468-2982.2002.00364.x","volume":"22","author":"M Bigal","year":"2002","unstructured":"Bigal M, Bordini C, Tepper S, Speciali J (2002) Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 22(5):345\u2013353","journal-title":"Cephalalgia"},{"issue":"5","key":"1931_CR78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S1481803500009593","volume":"6","author":"LR Frank","year":"2004","unstructured":"Frank LR, Olson CM, Shuler KB, Gharib SF (2004) Intravenous magnesium for acute benign headache in the emergency department: a randomized double-blind placebo-controlled trial. Can J Emerg Med 6(5):327\u2013332","journal-title":"Can J Emerg Med"},{"issue":"3","key":"1931_CR79","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-2982.2004.00840.x","volume":"25","author":"Y Cete","year":"2005","unstructured":"Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C (2005) A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia 25(3):199\u2013204","journal-title":"Cephalalgia"},{"issue":"1","key":"1931_CR80","first-page":"2","volume":"21","author":"H Choi","year":"2014","unstructured":"Choi H, Parmar N (2014) The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med 21(1):2\u20139","journal-title":"Eur J Emerg Med"},{"key":"1931_CR81","unstructured":"Kasmaei HD, Amiri M, Negida A, Hajimollarabi S, Mahdavi N (2017) Ketorolac versus magnesium sulfate in migraine headache pain management; a preliminary study. Emergency 5(1)"},{"issue":"3","key":"1931_CR82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3344\/kjp.2017.30.3.176","volume":"30","author":"A Baratloo","year":"2017","unstructured":"Baratloo A, Mirbaha S, Delavar Kasmaei H, Payandemehr P, Elmaraezy A, Negida A (2017) Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. Korean J Pain 30(3):176\u2013182","journal-title":"Korean J Pain"},{"key":"1931_CR83","unstructured":"Ha H, Gonzalez A (2019) Migraine headache prophylaxis. Am Fam Physician 99(1)"},{"key":"1931_CR84","doi-asserted-by":"crossref","unstructured":"Sprenger T, Viana M, Tassorelli C (2018) Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics:1\u201311","DOI":"10.1007\/s13311-018-0621-8"},{"issue":"1","key":"1931_CR85","first-page":"E97","volume":"19","author":"H-Y Chiu","year":"2016","unstructured":"Chiu H-Y, Yeh TH, Huang YC, Chen PY (2016) Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials. Pain Phys 19(1):E97\u2013E112","journal-title":"Pain Phys"},{"key":"1931_CR86","unstructured":"Pagliaro MJ, Pagliaro MM (2014) Method and device or pharmaceutical compositions for the transdermal delivery of magnesium directly to the neuromuscular junction for the treatment of muscle cramping. Google Patents"},{"issue":"8","key":"1931_CR87","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/nu9080813","volume":"9","author":"U Gr\u00f6ber","year":"2017","unstructured":"Gr\u00f6ber U, Werner T, Vormann J, Kisters K (2017) Myth or reality\u2014transdermal magnesium? Nutrients 9(8):813","journal-title":"Nutrients"},{"key":"1931_CR88","volume-title":"Holy Water, Sacred oil: the fountain of youth","author":"N Shealy","year":"2000","unstructured":"Shealy N (2000) Holy Water, Sacred oil: the fountain of youth. Biogenics Books, New York"},{"key":"1931_CR89","unstructured":"Sircus M (2011) Transdermal magnesium therapy: a new modality for the maintenance of health. iUniverse,"},{"issue":"2","key":"1931_CR90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2012.04.003","volume":"65","author":"OG Jepps","year":"2013","unstructured":"Jepps OG, Dancik Y, Anissimov YG, Roberts MS (2013) Modeling the human skin barrier\u2014Towards a better understanding of dermal absorption. Adv Drug Deliv Rev 65(2):152\u2013168","journal-title":"Adv Drug Deliv Rev"},{"key":"1931_CR91","unstructured":"Bourke B (2008) Magnesium chloride for health and rejuvenation."},{"key":"1931_CR92","unstructured":"Reddy B Achieving optimal health through transdermal magnesium therapy"},{"issue":"2","key":"1931_CR93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1684\/mrh.2016.0402","volume":"29","author":"NC Chandrasekaran","year":"2016","unstructured":"Chandrasekaran NC, Sanchez WY, Mohammed YH, Grice JE, Roberts MS, Barnard RT (2016) Permeation of topically applied Magnesium ions through human skin is facilitated by hair follicles. Magnes Res 29(2):35\u201342","journal-title":"Magnes Res"},{"key":"1931_CR94","first-page":"1","volume":"14","author":"K Watkins","year":"2010","unstructured":"Watkins K, Josling P (2010) A pilot study to determine the impact of transdermal magnesium treatment on serum levels and whole body CaMg ratios. Nutr Pract 14:1\u20137","journal-title":"Nutr Pract"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-019-01931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-019-01931-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-019-01931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T04:32:35Z","timestamp":1721968355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-019-01931-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1931"],"URL":"https:\/\/doi.org\/10.1007\/s12011-019-01931-z","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}